Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 April 2026, 15:00 (CEST) to 16 April 2026, 16:00 (CEST)

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 May 2026, 15:00 (CEST) to 13 May 2026, 16:00 (CEST)

Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 May 2026, 15:00 (CEST) to 12 May 2026, 16:00 (CEST)

Network Data Steering Group (NDSG)

HMA-EMA joint Network Data Steering Group meeting - 6 October 2025

Human medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 10, Status: Authorised

Agenda of the CAT meeting 3-5 December 2025

PSUSA/00002558/202501

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2025, 14:00 (CET) to 18 November 2025, 15:00 (CET)